Thermo Fisher Scientific (TMO) & Volcano Corp (VOLC) Financial Survey

Thermo Fisher Scientific (NYSE: TMO) and Volcano Corp (NASDAQ:VOLC) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, earnings and profitability.

Valuation and Earnings

This table compares Thermo Fisher Scientific and Volcano Corp’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio NetIncome Earnings Per Share Price/Earnings Ratio
Thermo Fisher Scientific $18.27 billion 4.09 $2.02 billion $5.89 31.61
Volcano Corp N/A N/A N/A ($0.74) N/A

Thermo Fisher Scientific has higher revenue and earnings than Volcano Corp. Volcano Corp is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks.

Dividends

Thermo Fisher Scientific pays an annual dividend of $0.60 per share and has a dividend yield of 0.3%. Volcano Corp does not pay a dividend. Thermo Fisher Scientific pays out 10.2% of its earnings in the form of a dividend.

Profitability

This table compares Thermo Fisher Scientific and Volcano Corp’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Thermo Fisher Scientific 11.73% 15.94% 7.41%
Volcano Corp -8.21% -10.48% -3.68%

Institutional and Insider Ownership

83.7% of Thermo Fisher Scientific shares are held by institutional investors. 0.5% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Thermo Fisher Scientific and Volcano Corp, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Thermo Fisher Scientific 0 1 14 0 2.93
Volcano Corp 0 0 0 0 N/A

Thermo Fisher Scientific presently has a consensus price target of $205.00, indicating a potential upside of 10.11%.

Summary

Thermo Fisher Scientific beats Volcano Corp on 9 of the 10 factors compared between the two stocks.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables. The Analytical Instruments segment provides a range of instruments, consumables, software and services. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers controlled temperature technologies products, growth protection and separation products, and water and laboratory products.

Volcano Corp Company Profile

Volcano Corporation designs, develops, manufactures and commercializes a suite of precision guided therapy tools including intravascular ultrasound (IVUS) and fractional flow reserve (FFR) products. The Company markets its products to physicians, nurses and technicians who perform endovascular based coronary and peripheral interventional procedures in hospitals and to other personnel who make purchasing decisions on behalf of hospitals. The Company’s products consist of consoles that are marketed as stand-alone units or as units that can be integrated into a variety of hospital-based interventional surgical suites called catheterization laboratories, or cath labs. The Company has developed customized cath lab versions of these consoles. The Company sells products directly to customers in the United States, Japan, certain European markets and South Africa. The Company’s products include consoles, IVUS products, FFR products, Pioneer plus re-entry catheter and crux VCF system.

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply